Suchergebnisse - "Best, Jennie H"

PubPharm (6)

1

Comparison of trajectories of self-monitored glucose levels by hypoglycemia status over 52 weeks of treatment with insulin glargine or exenatide once weekly

enthalten in: Journal of diabetes | 2016

von Paul, S. | Agbeve, J. | Maggs, D. | +1

2

Observational study of kidney function and albuminuria in patients with type 2 diabetes treated with exenatide BID versus insulin glargine

enthalten in: The Annals of pharmacotherapy | 2014

von Pawaskar, M. | Tuttle, K. | Li, Q. | +2

3

Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States : results from a retrospective claims database analysis

enthalten in: Journal of medical economics | 2012

von Pelletier, E. | Pawaskar, M. | Smith, P. | +2

4

Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States

enthalten in: Journal of medical economics | 2012

von Guillermin, A. | Lloyd, A. | Best, J. | +3

5

Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US

enthalten in: Journal of medical economics | 2012

von Samyshkin, Y. | Guillermin, A. | Best, J. | +2

6

Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment

enthalten in: Diabetes care | 2011

von Best, J. | Rubin, R. | Peyrot, M. | +4

1
[1]